BioMedInnovations dba BMI OrganBank has filed a notice of an exempt offering of securities to raise $9 Million in New Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, BioMedInnovations dba BMI OrganBank is raising up to $9,000,000.00 in new funding. Sources indicate that as part of senior management Chief Operating and Business Officer, Robert Neusner played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About BioMedInnovations dba BMI OrganBank
As perfusion experts, we work with leading academic institutions to expand organ transplantation possibilities and develop innovative medical devices to transform patient outcomes. BMI’s vision is to extend lives and quality of life, preserving and reconditioning tissues and organs by bringing novel solutions to patients, clinicians and researchers.
To learn more about BioMedInnovations dba BMI OrganBank, visit http://bmiorganbank.com/
Contact:
Robert Neusner, Chief Operating and Business Officer
704-413-7694
https://www.linkedin.com/in/robert-neusner-029548b/
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.